FBRX Stock Summary and Trading Ideas (Forte Biosciences | NASDAQ:FBRX)

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Forte Biosciences trades on the NASDAQ stock market under the symbol FBRX.

As of July 24, 2026, FBRX stock price declined to $54.78 with 556,237 million shares trading.

FBRX has a beta of 0.67, meaning it tends to be less sensitive to market movements. FBRX has a correlation of 0.00 to the broad based SPY ETF.

FBRX has a market cap of $1.12 billion. This is considered a Small Cap stock.

In the last 3 years, FBRX traded as high as $62.46 and as low as $4.11.

The top ETF exchange traded funds that FBRX belongs to (by Net Assets): IWM, VTI, IWO, VXF, ATFV.

FBRX has outperformed the market in the last year with a price return of +409.6% while the SPY ETF gained +17.7%. FBRX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +99.6% and +24.7%, respectively, while the SPY returned +3.8% and -2.1%, respectively.

FBRX support price is $54.86 and resistance is $64.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBRX shares will trade within this expected range on the day.